Here are relevant reports on : chronic-disease-management-market
-
Asia Pacific Patient Engagement Solutions Market by Therapy (Chronic [Obesity, Diabetes], Women’s Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient), Unmet Need, Investment - Forecast to 2030
The Asia Pacific Patient Engagement Solutions market, valued at USD 3.45 billion in 2024, stood at USD 3.97 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of USD 7.48 billion by the end of the period. This growth is driven by the rising demand for patient-centered and personalized care, a rapid expansion of telehealth and remote care frameworks, and more investments in digital healthcare infrastructure within the Asia Pacific region.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Gastroscopes Market by Type (Standard, Therapeutic, Dual Channel, Transnasal), Application (Gastric Ulcers, Chronic Gastritis, Normal Mucosa), End User (Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers) - Global Forecast to 2023.
The Global Gastroscopes market is expected to reach USD 2.57 billion by 2023 from USD 1.51 billion in 2018, growing at a CAGR of 11.2 % from 2018 to 2023. Growing occurrences of gastric disorders like ulcers and improvements in the gastroscope technology and equipments are expected to drive the growth of the market during the forecast period. The high cost of the product and the subsequent risk of infections upon its use may restrain the growth of the market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Wound Assessment Market by Product (Contact Wound Measuring Devices & Non-contact Wound Measuring Devices), Wound Type (Chronic Wounds and Acute Wounds) - Global Forecast to 2023
The global wound assessment Market was estimated at USD 13.00 million in 2018, and is estimated to reach USD 16 million by 2023, growing at a CAGR of 4.2% from 2018 to 2023. Recent studies revealed that wound treatment cost may reduce by ~89% and recently launched wound intelligent devices. Also, enhance the wound healing process by nine times. Penetration of advanced wound management products will be significantly impacting emerging economies as intelligent digital devices helps to curb the wound treatment cost.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Urology Surgical Instruments Market by Product (Endoscopes, Endovision Systems, Peripheral Instruments, Consumables and Accessories), Application (Chronic Kidney Diseases, Benign Prostatic Hyperplasia, Oncology) - Global Forecast to 2021
The global urology surgical instruments market size is projected to grow at a CAGR of 8.2%. The growth of this market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
Functional Endoscopic Sinus Surgery Market Size, Share & Trends by Product (Endoscopes (Sinuscopes, Rhinoscopes), Surgical Instruments, Navigation Systems), Procedure (Maxillary, Ethmoid), Indication (Chronic Sinusitis, Nasal Polyposis), Patient type - Global Forecast to 2029
The global functional endoscopic sinus surgery market, valued at US$1.1 billion in 2023, stood at US$1.2 billion in 2024 and is projected to advance at a resilient CAGR of 7.6% from 2024 to 2029, culminating in a forecasted valuation of US$1.7 billion by the end of the period. The growth in this market is due to a significant shift towards minimally invasive, in-office surgery which is a more patient-friendly substitute. This has an added advantage over traditional procedures, for instance, less anaesthesia, more convenient, faster turn around times, and at reduced costs.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Europe Patient Engagement Solutions Market by Therapy (Chronic [CVD, Obesity], Women's Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing, Education), End User (Hospitals, ASCs, Payers, Patients) - Forecast to 2030
The Europe Patient Engagement Solutions market, valued at USD 6.42 billion in 2024, stood at USD 7.35 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD 13.37 billion by the end of the period. This development is fueled by the changing trend toward value-based and outcome-oriented care, escalating the need to provide continuous interaction with patients outside of clinical care, and an increasing use of digital front-door solutions (patient portals and virtual assistants).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Bioactive Dressings Market by Product (Collagen, Alginate, Chitosan, Skin Substitute), Property (Antimicrobial, Non-antimicrobial), Application (Chronic Wounds (Diabetic Foot, Pressure Ulcers), Acute Wounds (Surgical, Burns))- Global Forecast to 2029
The global bioactive dressings market, valued at US$3.2 billion in 2023, stood at US$3.5 billion in 2024 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2029, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The need for cutting-edge therapeutic solutions to address the growing incidence of chronic ewounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, is driving the market for bioactive wound dressings.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers), Wounds (Chronic, Acute)), End User (Hospitals, Clinics, Home Care), and Region - Global Forecast to 2030
The global wound care market, valued at USD 20.97 billion in 2024, stood at USD 22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of USD 30.48 billion by the end of the period. The wound care market is primarily driven by the increasing cases of traumatic and burn injuries, growing prevalence of chronic diseases, and rising geriatric population. These factors have contributed to the higher demand for effective wound management solutions.
- Published: July 2025
- Price: $ 8150
- TOC Available:
-
Neurosurgery Devices Market by Product (Neuromodulation(Spinal Cord Stimulation, Deep Brain Stimulation) Neuroendoscopy), Application (Chronic Pain, Depression, Parkinsons, Ischemia, Transnasal Neuroendoscopy), Region - Global Forecast to 2024
The Neurosurgery Devices Market is expected to grow from USD 7.3 billion in 2019 to USD 13.5 billion by 2024, at a CAGR of 13.0% during the forecast period. Major players operating in the neurosurgery devices market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
- Published: September 2019
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
